MCID: NRV007
MIFTS: 71

Nervous System Disease malady

Categories: Neuronal diseases, Immune diseases

Aliases & Classifications for Nervous System Disease

Summaries for Nervous System Disease

Disease Ontology : 12 A disease of anatomical entity that is located in the central nervous system or located in the peripheral nervous system.

MalaCards based summary : Nervous System Disease, also known as nervous system diseases, is related to neuropathy and measles, and has symptoms including aphonia, ataxia and athetosis. An important gene associated with Nervous System Disease is MOG (Myelin Oligodendrocyte Glycoprotein), and among its related pathways/superpathways are Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. and RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways. The drugs Ethanol and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include skin, tongue and t cells, and related phenotypes are cellular and homeostasis/metabolism

Wikipedia : 71 Nervous system disease refers to a general class of medical conditions affecting the nervous... more...

Related Diseases for Nervous System Disease

Diseases in the Nervous System Disease family:

Autoimmune Disease of Central Nervous System Congenital Nervous System Abnormality
Central Nervous System Disease

Diseases related to Nervous System Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 475)
id Related Disease Score Top Affiliating Genes
1 neuropathy 32.1 IL1B IL6 TNF
2 measles 30.6 IL1B IL6 TNF
3 hepatitis 30.2 IFNG IL6 TNF
4 collagenous colitis 30.0 IFNG IL1B IL6 NOS2 TNF
5 central nervous system lymphoma 29.9 IL1B IL6 TNF
6 tuberculosis 29.9 IL1B IL6 TNF
7 choroiditis 29.9 IL1B IL6 TNF
8 central nervous system disease 12.4
9 peripheral nervous system disease 12.3
10 autonomic nervous system disease 12.1
11 neuronitis 10.9
12 meningitis 10.9
13 autonomic peripheral neuropathy 10.9
14 multiple sclerosis, disease progression, modifier of 10.6
15 central hypoventilation syndrome, congenital 10.6
16 amyotrophy, hereditary neuralgic 10.6
17 amyotrophic lateral sclerosis 1 10.6
18 neuromyelitis optica 10.6
19 granulomatous amebic encephalitis 10.6
20 restless legs syndrome 10.6
21 hyperekplexia 10.6
22 intracranial abscess 10.6
23 meningoencephalitis 10.6
24 epidural abscess 10.6
25 cauda equina syndrome 10.6
26 locked-in syndrome 10.6
27 neuroleptic malignant syndrome 10.6
28 toxic encephalopathy 10.6
29 gerstmann syndrome 10.6
30 stocco dos santos syndrome 10.5 IFNG IL1B TNF
31 cervical adenoid basal carcinoma 10.5 IL1B MBP MOG
32 intussusception 10.5 IL1B TNF
33 osteodysplasty precocious of danks mayne and kozlowski 10.5 CXCR3 IFNG TNF
34 amyotrophic lateral sclerosis type 14 10.5 IFNG IL1B NOS2 TNF
35 anal paget's disease 10.5 IL1B IL6 TNF
36 balkan nephropathy 10.5 CXCR3 IFNG IL1B TNF
37 benign eccrine breast spiradenoma 10.5 CXCR3 IFNG IL1B TNF
38 cataract 10.5 CSF2 IL1B TNF
39 parkinson disease 11 10.5 IFNG IL1B TNF
40 bipolar i disorder 10.5 IL1B IL6 TNF
41 cyclosporiasis 10.5 CXCR3 IFNG IL6 TNF
42 aniseikonia 10.5 CSF2 IFNG TNF
43 human immunodeficiency virus infectious disease 10.5 IL1B IL6 TNF
44 venezuelan hemorrhagic fever 10.5 CXCR3 IFNG TNF
45 bladder signet ring cell adenocarcinoma 10.5 IL1B IL6 MBP TNF
46 status epilepticus 10.5 IFNG IL1B MBP MOG TNF
47 tinea capitis 10.5 IL1B IL6 TNF
48 leydig cell hypoplasia 10.5 IL6 MBP NOS2 TNF
49 burns 10.5 CXCR3 IFNG IL6 TNF
50 senile reticular retinal degeneration 10.5 IFNG IL1B TNF

Comorbidity relations with Nervous System Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Hypertension, Essential
Schizophreniform Disorder

Graphical network of the top 20 diseases related to Nervous System Disease:



Diseases related to Nervous System Disease

Symptoms & Phenotypes for Nervous System Disease

UMLS symptoms related to Nervous System Disease:


aphonia, ataxia, athetosis, back pain, cerebellar ataxia, cheyne-stokes respiration, dizziness, muscular fasciculation, headache, hemiparesis, hemiplegia, hoarseness, hyperalgesia, hyperesthesia, leg cramps, meningism, flaccid muscle tone, muscle rigidity, muscle spasticity, myoclonus, neuralgia, numbness, ophthalmoplegia, pain, paresis, reflex, abnormal, sciatica, seizures, spasm, pathological conditions, signs and symptoms, syncope, torticollis, tremor, vertigo, flaccid paralysis, burning sensation, hypalgesia, agitation, lassitude, chronic pain, scalp tenderness, cogwheel rigidity, opisthotonus, circumoral paresthesia, spasmodic torticollis, lightheadedness, muscular stiffness, musculoskeletal symptom, muscular incoordination, muscle fibrillation, asterixis, bradykinesia, micropsia, clumsiness, asynergia, adiadochokinesis, fine tremor, coarse tremor, action tremor, epileptic aura, lid retraction, application site anesthesia, injection site anesthesia, spasm oropharyngeal, astasia, dysdiadochokinesis, fumbling, head discomfort, head pressure, head tightness, hypersensation skin, bulging fontanelle, numbness localized, neurologic symptoms, paresthesia, distal, paresthesia mucosal, paresthesia skin, tingling of skin, skeletal muscle paralysis, paralysis muscle general skeletal, paralysis muscle local skeletal, paralysis lower motor neuron type, scotoma, scintillating, tongue sluggish, tremor, perioral, tremor, muscle, nerve tremors, dyskinesia neonatal, tremor, neonatal, absence attacks, anesthesia mouth, anesthesia lip, anesthesia oral mucosa, anesthesia tongue, burning sensation of skin, post-lumbar puncture headache, seizures, tonic, extreme exhaustion, agitation mental, akathisia, dysesthesia, rigor - temperature-associated observation, involuntary movements, vertigo/dizziness, abnormal coordination, burning mucosal, paresthesia mouth, numb mouth, eyes rolling, electric shock sensation, jaw stiffness, equilibration disorder, muzzy headed, clouded consciousness, motor restlessness, decreased tendon reflex, myotonus (finding), reaction to spinal or lumbar puncture, staggering gait, non-epileptic convulsion, gait ataxia, headache fullness, sleeplessness, symptoms

MGI Mouse Phenotypes related to Nervous System Disease:

44 (show all 22)
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.52 APOE APP BACE1 CCR1 CSF2 CXCR3
2 homeostasis/metabolism MP:0005376 10.48 APOE APP BACE1 CCR1 CSF2 CXCR3
3 behavior/neurological MP:0005386 10.45 APOE APP BACE1 CSF2 IFNG IL6
4 immune system MP:0005387 10.44 MTDH NOS2 PRNP PSEN1 SNCA TNF
5 hematopoietic system MP:0005397 10.43 CXCR3 IFNG IL1B IL6 MBP MOG
6 mortality/aging MP:0010768 10.42 APOE APP BACE1 CCR1 CSF2 CXCR3
7 cardiovascular system MP:0005385 10.41 APOE CCR1 CSF2 CXCR3 IFNG IL1B
8 growth/size/body region MP:0005378 10.41 APOE APP BACE1 CSF2 IFNG IL6
9 integument MP:0010771 10.34 IL6 APOE APP BACE1 CSF2 IFNG
10 nervous system MP:0003631 10.34 APOE APP BACE1 CSF2 IFNG IL1B
11 endocrine/exocrine gland MP:0005379 10.32 IFNG IL6 MTDH NOS2 PRNP PSEN1
12 digestive/alimentary MP:0005381 10.19 APOE CCR1 IFNG IL6 NOS2 PSEN1
13 muscle MP:0005369 10.18 APOE APP BACE1 IFNG IL6 MOG
14 neoplasm MP:0002006 10.11 PROM1 TNF CSF2 CXCR3 IFNG IL1B
15 normal MP:0002873 10.07 BACE1 CXCR3 IFNG MBP MTDH PRNP
16 liver/biliary system MP:0005370 10.05 IL6 MTDH NOS2 TNF APOE CCR1
17 reproductive system MP:0005389 10.03 MBP MTDH NOS2 PRNP PSEN1 SNCA
18 no phenotypic analysis MP:0003012 10.01 APOE APP BACE1 IFNG PRNP PROM1
19 renal/urinary system MP:0005367 9.97 APOE CCR1 CSF2 CXCR3 IFNG IL6
20 respiratory system MP:0005388 9.81 APOE CCR1 CSF2 CXCR3 IFNG IL6
21 skeleton MP:0005390 9.7 APOE CSF2 GC IFNG IL1B IL6
22 vision/eye MP:0005391 9.36 APOE IFNG IL6 MBP MFRP MOG

Drugs & Therapeutics for Nervous System Disease

Drugs for Nervous System Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1146)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 64-17-5 702
2
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
3
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
4
Mannitol Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 69-65-8 453 6251
5
Lamotrigine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 84057-84-1 3878
6
Carbamazepine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 298-46-4 2554
7
Baclofen Approved Phase 4,Phase 3,Phase 2,Phase 1 1134-47-0 2284
8
Imipramine Approved Phase 4,Phase 3 50-49-7 3696
9
Levodopa Approved Phase 4,Phase 3,Phase 2,Phase 1 59-92-7 6047
10
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 50-28-2 5757 53477783
11
Epinephrine Approved, Vet_approved Phase 4,Phase 2 51-43-4 5816
12
Midazolam Approved, Illicit Phase 4,Phase 3,Phase 2,Phase 1 59467-70-8 4192
13
Iron Approved Phase 4,Phase 2,Phase 1,Early Phase 1 7439-89-6 23925
14
Mycophenolic acid Approved Phase 4,Phase 2,Phase 1 24280-93-1 446541
15
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 2,Phase 1 128794-94-5 5281078
16
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 57-27-2 5288826
17
Acetaminophen Approved Phase 4,Phase 3,Phase 2 103-90-2 1983
18
Metformin Approved Phase 4 657-24-9 14219 4091
19
Valproic Acid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 99-66-1 3121
20 Moxonidine Approved Phase 4 75438-57-2 4810
21
Donepezil Approved Phase 4,Phase 3,Phase 2,Phase 1 120014-06-4 3152
22
Galantamine Approved Phase 4,Phase 3 357-70-0 9651 908828, 9651
23
Rivastigmine Approved, Investigational Phase 4,Phase 1 123441-03-2 77991
24
Acetylcholine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-84-3 187
25
Memantine Approved, Investigational Phase 4 19982-08-2 4054
26 Piracetam Approved Phase 4,Phase 3,Phase 2,Phase 1 7491-74-9
27
Rocuronium Approved Phase 4,Phase 1 119302-91-9, 143558-00-3 441290
28
Metoclopramide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 364-62-5 4168
29
Propranolol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 525-66-6 4946
30
Topiramate Approved Phase 4,Phase 3,Phase 1,Phase 2 97240-79-4 5284627
31
Risperidone Approved, Investigational Phase 4,Phase 2,Phase 1 106266-06-2 5073
32
Methylphenidate Approved, Investigational Phase 4,Phase 3,Phase 2 113-45-1 4158
33
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 76631-46-4, 113775-47-6 68602 5311068 56032
34
Amphetamine Approved, Illicit Phase 4,Phase 2,Phase 1 300-62-9 5826 3007
35
Capsaicin Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 404-86-4 1548943
36
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
37
Sevoflurane Approved, Vet_approved Phase 4,Phase 3 28523-86-6 5206
38
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 137-58-6 3676
39
Cysteamine Approved, Investigational Phase 4 60-23-1 6058
40
Remifentanil Approved Phase 4,Phase 3,Phase 2,Phase 1 132875-61-7 60815
41
Amitriptyline Approved Phase 4,Phase 3,Phase 2 50-48-6 2160
42
Dacarbazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 4342-03-4 5351166
43
Citalopram Approved Phase 4,Phase 2,Phase 1 59729-33-8 2771
44
Ketamine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 6740-88-1 3821
45
Methadone Approved Phase 4,Phase 3,Phase 2 76-99-3 4095
46
Temozolomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 85622-93-1 5394
47
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 2078-54-8 4943
48
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 124-94-7 31307
49
Tramadol Approved, Investigational Phase 4,Phase 3,Phase 2 27203-92-5 33741
50
Zolpidem Approved Phase 4 82626-48-0 5732

Interventional clinical trials:

(show top 50) (show all 5000)
id Name Status NCT ID Phase
1 Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU) Unknown status NCT01319643 Phase 4
2 Controlled Trial of Deep Brain Stimulation in Early Patients With Parkinson's Disease Unknown status NCT00354133 Phase 4
3 Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity Unknown status NCT01786005 Phase 4
4 How Many Patients Are in Need of Vitamin B12 Injections? Unknown status NCT00326833 Phase 4
5 Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics Unknown status NCT00845936 Phase 4
6 Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2 Unknown status NCT00473733 Phase 4
7 Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy Unknown status NCT00123136 Phase 4
8 Cognitive Decline in Non-demented PD Unknown status NCT01340885 Phase 4
9 Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy Unknown status NCT01052337 Phase 4
10 ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study Unknown status NCT01881711 Phase 4
11 Inspiratory Muscle Training in Patients With Autonomic Neuropathic Unknown status NCT00752440 Phase 4
12 Major Depressive Disorder - Understanding The Link Between The Brain And The Heart Unknown status NCT01568307 Phase 4
13 Oxepa in Multiple Trauma Unknown status NCT01099501 Phase 4
14 NIMIP: Non Invasive Measurement of the Intracranial Pressure Unknown status NCT01685450 Phase 4
15 A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy Unknown status NCT01875562 Phase 4
16 Imipramine and Pregabalin Combination in Painful Polyneuropathy Unknown status NCT01047488 Phase 4
17 Hormone Profiles in Adults With Newly Diagnosed Epilepsy Unknown status NCT00137709 Phase 4
18 Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD) Unknown status NCT01483053 Phase 4
19 Cognitive and Behavioral Effects of Lacosamide Unknown status NCT01175954 Phase 4
20 The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy Unknown status NCT00647322 Phase 4
21 Study to Improve the Treatment of Epilepsy (SITE) Unknown status NCT00133081 Phase 4
22 Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease Unknown status NCT01094769 Phase 4
23 Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study Unknown status NCT01361373 Phase 4
24 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Different Forms of Depakote Unknown status NCT00312676 Phase 4
25 Eyegaze Systems for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943656 Phase 4
26 Exoskeletons for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943669 Phase 4
27 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
28 Does Oral Baclofen Improve Care and Comfort in Spastic Children in Nursing Homes? Unknown status NCT00752934 Phase 4
29 Sleep Disturbances in Hospitalized Children Unknown status NCT00749814 Phase 4
30 Understanding of Chest Pain in Microvascular Disease Proved by Cardiac Magnetic Resonance Image Unknown status NCT01769482 Phase 4
31 Study on Magnetic Field Therapy to Improve Chronic Lumbar Pain Unknown status NCT00444990 Phase 4
32 Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy Unknown status NCT00129597 Phase 4
33 Effect of Rozerem on Sleep Among People With Traumatic Brain Injury Unknown status NCT01207050 Phase 4
34 Bilateral Superficial Cervical Block for Thyroidectomy Unknown status NCT01171885 Phase 4
35 Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients Unknown status NCT02134093 Phase 4
36 A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain Unknown status NCT02289261 Phase 4
37 The Effect of Ketamine Infusion on Lumbar Surgery Unknown status NCT02154438 Phase 4
38 Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General Anesthesia Unknown status NCT02141737 Phase 4
39 Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases Completed NCT00404729 Phase 4
40 Dexmedetomidine in Patients After Intracranial Surgery Completed NCT01445639 Phase 4
41 Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy Completed NCT01524861 Phase 4
42 Comparison of the Analgesic Effect of Different Local Anesthetics in Interscalene Nerve Block for Shoulder Surgery Completed NCT02691442 Phase 4
43 Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China Completed NCT01340950 Phase 4
44 Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance Completed NCT00060866 Phase 4
45 Replagal Enzyme Replacement Therapy for Adults With Fabry Disease Completed NCT00097890 Phase 4
46 Donepezil to Treat Dementia in Parkinson's Disease Completed NCT00030979 Phase 4
47 Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors Completed NCT00075166 Phase 4
48 Nutritional and Metabolic Evaluation of a Tube Feeding Immune Enhancing Diet in ICU Patients Completed NCT00560157 Phase 4
49 Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled Study Completed NCT00466778 Phase 4
50 Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy Completed NCT00380965 Phase 4

Search NIH Clinical Center for Nervous System Disease

Cochrane evidence based reviews: nervous system diseases

Genetic Tests for Nervous System Disease

Genetic tests related to Nervous System Disease:

id Genetic test Affiliating Genes
1 Abnormality of the Nervous System 29

Anatomical Context for Nervous System Disease

MalaCards organs/tissues related to Nervous System Disease:

39
Skin, Tongue, T Cells, Brain, Eye, Skeletal Muscle, Myeloid

The Foundational Model of Anatomy Ontology organs/tissues related to Nervous System Disease:

18
The Central Nervous System Or

Publications for Nervous System Disease

Articles related to Nervous System Disease:

(show top 50) (show all 344)
id Title Authors Year
1
Highly Expandable Human iPS Cell-Derived Neural Progenitor Cells (NPC) and Neurons for Central Nervous System Disease Modeling and High-Throughput Screening. ( 28075486 )
2017
2
AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis. ( 27354217 )
2016
3
Central nervous system disease and genital disease in harbor porpoises (Phocoena phocoena) are associated with different herpesviruses. ( 26861818 )
2016
4
Delivery of an adeno-associated virus vector into CSF attenuates central nervous system disease in mucopolysaccharidosis type II mice. ( 27510804 )
2016
5
Fatal Central Nervous System Disease Following First Infliximab Infusion in a Child With Inflammatory Bowel Disease. ( 26831951 )
2016
6
An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease. ( 26843629 )
2016
7
Raccoon Roundworm Infection Associated with Central Nervous System Disease and Ocular Disease - Six States, 2013-2015. ( 27608169 )
2016
8
Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe'sA disease). ( 27638585 )
2016
9
Association of Resident Duty Hour Restrictions on Mortality of Nervous System Disease and Disorder. ( 27777670 )
2016
10
Molecular Analysis of Central Nervous System Disease Spectrum in Childhood Acute Lymphoblastic Leukemia. ( 26997880 )
2016
11
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability. ( 27133811 )
2016
12
Clinical and Laboratory Findings That Differentiate Herpes Simplex Virus Central Nervous System Disease from Enteroviral Meningitis. ( 27563314 )
2016
13
Central nervous system disease in childhood acute lymphoblastic leukaemia- a review. ( 26990196 )
2016
14
Glial biomarkers in human central nervous system disease. ( 27228454 )
2016
15
Hodgkin Lymphoma With Central Nervous System Disease at Primary Presentation. ( 26814676 )
2016
16
Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients. ( 25677878 )
2015
17
Macaque species susceptibility to simian immunodeficiency virus: increased incidence of SIV central nervous system disease in pigtailed macaques versus rhesus macaques. ( 25672885 )
2015
18
Intranasal delivery of stem cells as therapy for central nervous system disease. ( 25645932 )
2015
19
Targeted Temperature Management in Pediatric Central Nervous System Disease. ( 26042193 )
2015
20
Flow cytometry for detection of central nervous system disease in acute myeloid leukemia. ( 25641427 )
2015
21
Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease. ( 25474439 )
2015
22
Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease. ( 26793168 )
2015
23
Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here? ( 26314739 )
2015
24
Recurrent neonatal herpes simplex virus infection with central nervous system disease after completion of a 6-month course of suppressive therapy: Case report. ( 26390826 )
2015
25
Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII. ( 26447927 )
2015
26
Current developments in understanding of West Nile virus central nervous system disease. ( 24722324 )
2014
27
Evaluation of malnutrition in patients with nervous system disease. ( 25192880 )
2014
28
Coxsackievirus-induced acute neonatal central nervous system disease model. ( 24696707 )
2014
29
Attribution in the assessment of nervous system disease in SLE. ( 25480812 )
2014
30
Neonatal Herpes Simplex Virus Type-1 Central Nervous System Disease with Acute Retinal Necrosis. ( 24378951 )
2014
31
ELR(+) chemokine signaling in host defense and disease in a viral model of central nervous system disease. ( 24987333 )
2014
32
RNA-sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease. ( 25258010 )
2014
33
Distinct systemic and central nervous system disease patterns in enterovirus and parechovirus infected children. ( 24662038 )
2014
34
A coumarin-based fluorescent probe as a central nervous system disease biomarker. ( 25390405 )
2014
35
RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease. ( 24043899 )
2013
36
Stress cardiomyopathy (tako-tsubo) triggered by nervous system diseases: a systematic review of the reported cases. ( 23415170 )
2013
37
Targeting epigenetics in nervous system disease. ( 23244434 )
2013
38
The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease. ( 23889991 )
2013
39
Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. ( 23817781 )
2013
40
Detection and characterization of a divergent avian reovirus strain from a broiler chicken with central nervous system disease. ( 23771766 )
2013
41
HIV-Associated Central Nervous System Disease in Patients Admitted at the Douala General Hospital between 2004 and 2009: A Retrospective Study. ( 23533732 )
2013
42
Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation. ( 24124621 )
2013
43
Epstein-Barr virus (EBV) load in cerebrospinal fluid and peripheral blood of patients with EBV-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation. ( 23692640 )
2013
44
Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. ( 21692072 )
2012
45
Liposomal cytarabine in central nervous system disease of haematological malignancies: more effective but more toxic? ( 22484630 )
2012
46
Post-transplant lymphoproliferative disorder: the significance of central nervous system disease. ( 22717024 )
2012
47
Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. ( 22680628 )
2012
48
Magnetic resonance spectroscopy--a non-invasive method in evaluating focal and diffuse central nervous system disease. ( 23346244 )
2012
49
HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. ( 22675662 )
2012
50
Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. ( 20674814 )
2011